Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Events

08 Dec 2026 - 10 Dec 2026
25 Jan 2027 - 28 Jan 2027

The Days of Glucose Finger Prick Tests May Be Numbered

By HospiMedica International staff writers
Posted on 14 Apr 2011
Consistent blood glucose monitoring based on painful finger pricking could soon be a thing of the past, thanks to a novel prototype sensor that will measure the amount of glucose in a tear drop. More...


Researchers at Arizona State University (ASU; Phoenix, USA) and the Mayo Clinic (Rochester, MN, USA) are developing the new sensor, which has already demonstrated proof-of-concept, as the amount of glucose in tears closely correlates with the amount of glucose in the blood. The device incorporates screen-printed sensors integrated with a silicone rubber fluidics system and absorbent polyurethane foam. In laboratory tests, a simulated eye surface was prepared using fluid-saturated poly(2-hydroxyethyl methacrylate) sheets; the disposable prototype was then tested for both reproducibility at 0 µmol/L, 200 µmol/L, and 400 µmol/L glucose and dynamic range of glucose detection from 0 µmol/L to 1000 µmol/L glucose.

Testing of the integrated prototype demonstrated a satisfactory lower limit of detection for measuring glucose concentration in tears, and was reproducible across a physiological sampling range. The next step in the device design process will be initial animal studies to evaluate the current prototype for factors such as eye irritation, ease of use, and correlation with blood glucose. The major challenges now facing the researchers are performing the test quickly, efficiently, with reproducible results, without letting the test sample evaporate, and without stimulating a stress response that causes people to rub their eyes intensely.

"The problem with current self-monitoring blood glucose technologies is not so much the sensor,” said codeveloper bioengineer Jeffrey LaBelle, PhD, of ASU. "It's the painful finger prick that makes people reluctant to perform the test. This new technology might encourage patients to check their blood sugars more often, which could lead to better control of their diabetes by a simple touch to the eye.”

Because of its potential impact on health care, the technology has drawn interest from BioAccel (Phoenix, USA), a nonprofit organization that works to accelerate efforts to bring biomedical technologies to the marketplace. BioAccel will provide assistance using a network of technical and business experts, while the researchers will compile the proper data set to allow for approval of human testing of the device.

"A critical element to commercialization is the validation of technology through proof-of -concept testing,” said Nikki Corday, BioAccel business and development manager. "Positive results will help ensure that the data is available to help the research team clear the technical hurdles to commercialization.”

Related Links:

Arizona State University
Mayo Clinic
BioAccel



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Vessel Sealing Instrument
ERGOseal
Fetal Monitor
BT-380
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: A view inside the custom virtual reality environment used in the study: a calm room with a teddy bear, soft colors and large windows looking out over the sea. (Image Credit: Walaa S. Abu Rukbah et al., Virginia Commonwealth University; CC-BY 4.0, https://creativecommons.org/licenses/by/4.0/)

Virtual Reality Program May Reduce Anxiety Before Pediatric Surgery

Presurgery anxiety affects an estimated 50% to 75% of children undergoing surgery and can complicate anesthesia induction, increase postoperative pain, and prolong recovery. Sedation is often used to manage... Read more

Medical Imaging

view channel
Image Credit: Adobe Stock

Lung Ultrasound Predicts Progression of Interstitial Lung Abnormalities in Rheumatoid Arthritis

Interstitial lung abnormalities are a pulmonary concern in patients with rheumatoid arthritis, requiring monitoring to detect disease progression. However, tracking these changes often involves repeated... Read more

Point of Care

view channel
Image: Jessica Ramella-Roman, professor of biomedical engineering at Florida International University, holding the PPRIM (Portable Preterm Imaging) device designed to detect early signs of preterm labor risk. (Photo courtesy of Florida International University)

Handheld Imaging Device May Help Identify Preterm Birth Risk Earlier

Preterm birth, defined as delivery before 37 weeks of pregnancy, can lead to serious neonatal complications, including neurological, developmental, and respiratory problems. However, identifying pregnancies... Read more

Business

view channel
Image: Stryker has acquired ZuriMED, adding the FiberLocker System, a rotator cuff augmentation technology designed to strengthen repairs, to its Sports Medicine portfolio. (Photo courtesy of ZuriMED)

Stryker Completes Acquisition to Broaden Shoulder Surgery Offerings

Stryker (Portage, MI, USA) has completed its acquisition of ZuriMED (Zurich, Switzerland), a privately held developer of the FiberLocker System, expanding its Sports Medicine portfolio with a commercialized... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.